Researchers have been trying to understand why and how certain lymphoma treatments often stop being effective. Lixin Rui and his team believe they’ve found the reason — and a potential alternative treatment.
Findings reveal the likely reason why certain chemotherapies are effective for many patients. Importantly, they also help explain why attempts to find new chemo drugs based solely on stopping cellular division have been so disappointing.
The midbody’s involvement in cell signaling and stimulating cell proliferation has been investigated before, but UW researchers wanted to look inside the midbody remnants to learn more.
UW researchers at the Carbone Cancer Center have identified the cells that can cause graft-versus-host disease, the most common complication of bone marrow transplants.
UW–Madison researchers have developed a method for early cancer detection using blood plasma, machine learning and equipment commonly found in medical labs.
A UW–Madison research team has discovered a direct link between cellular pathways that make promising targets for new cancer treatments.
By exploring the ways mice responded, researchers hope to gain an understanding of the sorts of human health issues that may bring on a case of this life-threatening form of cancer.
This year’s winter graduates are an accomplished bunch — they’ve created new student organizations, toured the world on music stages, undertaken important research, and won major awards
The two subtypes respond differently — information that could one day help physicians match patients with the therapies best suited to their disease.
UW–Madison and University of Pittsburgh scientists report the method works even when the radiation is given in doses too low to destroy the cancer outright.
Currently, cancers are detected using more invasive methods. Urinalysis has long been used to manage many diseases and disorders, but not cancer.
“We believe we are launching a new cancer therapy field here,” says Jamey Weichert, professor of radiology. “It’s very exciting, and the research team is incredible.”
The University of Wisconsin Carbone Cancer Center continues to care for cancer patients by using telehealth technology, expanding screening, and extending in-home care options to address the unique challenges created by the COVID-19 pandemic.
Jordan, a groundbreaking cancer researcher, and Moore, a pioneer in the field of contemporary distance education, will be awarded honorary doctoral degrees during the winter 2020 commencement ceremonies in December.
A 7-year-old Golden Retriever named Scout and UW–Madison’s School of Veterinary Medicine are already stealing the show in the run-up to the Super Bowl. Scout’s story, in the form of a 30-second commercial for WeatherTech, has already received an overwhelming reaction since it was first released on Tuesday.
If they are shown to work as well in the body as they do in pharmacy Professor Seungpyo Hong’s lab, the nanoparticles might provide an effective and more affordable way to fight cancer.
As Super Bowl LIV airs Sunday, Feb. 2, Scout will appear alongside members of the school’s faculty and staff who have been part of the 7-year-old golden retriever’s cancer treatment journey.
When clinicians at the University of Wisconsin School of Veterinary Medicine began caring for Scout in July 2019, they had no idea they would soon inspire, and appear in, a Super Bowl commercial. But they had a canine star on their hands, and a very appreciative client. Here is the finished ad.
The story of the care “Lucky Dog” Scout is receiving from the UW School of Veterinary Medicine is told here by David MacNeil and the veterinary team. Video by UW–Madison.
Colleagues at the UW Carbone Cancer Center are leading efforts to better understand how chromosome segregation goes wrong and contributes to disease.